Eliem Therapeutics, Inc. (ELYM) Tops Q4 EPS by 4c

Eliem Therapeutics, Inc. (NASDAQ: ELYM) reported Q4 EPS of ($0.29), $0.04 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Eliem Therapeutics, Inc. (ELYM) click here.

You May Also Be Interested In

• Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
• National Vision (EYE) Tops Q2 EPS by 7c; Offers Guidance
• Lightwave Logic, Inc. (LWLG) Reports Q2 Loss of $0.04